Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
NADPH oxidase regulates efficacy of vaccination in aspergillosis
George S. Deepe Jr.
George S. Deepe Jr.
Published April 23, 2012
Citation Information: J Clin Invest. 2012;122(5):1608-1611. https://doi.org/10.1172/JCI63417.
View: Text | PDF
Commentary

NADPH oxidase regulates efficacy of vaccination in aspergillosis

  • Text
  • PDF
Abstract

Invasive aspergillosis is often a consequence of immune suppression, and accumulating evidence points to a role for adaptive immunity. Hence, it may be possible to manipulate the adaptive immune system to enhance protective immunity in at-risk individuals. In this issue of the JCI, De Luca and colleagues describe the ontogeny of adaptive immune responses to murine aspergillosis infection in relation to vaccination. Their thought-provoking findings reveal the complexities of vaccine-induced immunity and could be used to improve vaccine efficacy.

Authors

George S. Deepe Jr.

×

Figure 2

CD4+ and CD8+ T cell recognition of Aspergillus antigens.

Options: View larger image (or click on image) Download as PowerPoint
CD4+ and CD8+ T cell recognition of Aspergillus antigens.
   
(A) Solubl...
(A) Soluble antigens such as Pep1, when admixed with soluble antigen, enter the MHC class II pathway whether NADPH oxidase is present or not and promote the development of protective CD4+ cells. (B) On the other hand, particulate immunogens such as conidia enter the MHC class I pathway but only activate CD8+ cells in the presence of NADPH oxidase. The lack of this oxidase, as in CGD, is associated with a failure to induce autophagy and endosomal alkalinization. This defect results in absent activation of CD8+ cells.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts